The Food and Drug Administration (FDA) should develop and implement a more comprehensive plan to review and track information security risks for implantable medical devices that use hardware, software and networks to wirelessly monitor a patient's medical status, according to a new report from the Government Accountability Office (GAO). Potential vulnerabilities include untested software and firmware, limited battery life and unauthorized changes to device settings due to a lack of appropriate access controls, GAO states. In comments in the report, Health & Human Services concurred with the recommendation and described efforts FDA has initiated.
HFM Daily offers blog coverage by the award-winning HFM editorial team and links to in-depth information on health care design, construction, engineering, environmental services, operations and technology. You can read HFM Daily stories on this page or subscribe to Health Facilities Management This Week for a Friday roundup of the week's posts.
<![if !(IE 6)]><![endif]>
GAO tells FDA to strengthen review of implantable devices
November 2012 Checklist
November 1, 2012